Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke
NCT02184260 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2014-07-10
Summary
Clinical efficacy and safety of Metamizole 2 g i.v. versus placebo, as antithermic therapy in the acute phase of ischemic stroke.
Conditions
Interventions
- DRUG
-
Metamizole
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-12-31
- Primary Completion
- 2002-05-31
More Related Trials
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
NCT01678534 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
NCT05070260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)
NCT00540527 ·Status: COMPLETED ·Phase: PHASE3
-
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke
NCT04280003 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
NCT05663307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
NCT02930837 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
NCT00044057 ·Status: COMPLETED ·Phase: PHASE2
-
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
NCT02822144 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
NCT01282242 ·Status: COMPLETED ·Phase: PHASE2
-
Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial
NCT03772847 ·Status: COMPLETED ·Phase: PHASE4
-
Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NCT04674293 ·Status: UNKNOWN
-
Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
NCT00123305 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety Study of PP-007 in Subjects With Acute Ischemic Stroke
NCT04677777 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
NCT02251197 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
NCT01800357 ·Status: UNKNOWN ·Phase: PHASE2
-
Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
NCT04256473 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke
NCT06700824 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
NCT00283088 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
NCT04952064 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2